20/20 Biolabs, Inc.
AIDX
$0.53
$0.012.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.81M | -5.15M | -3.74M | -3.68M | -4.73M |
| Total Depreciation and Amortization | 78.90K | 80.20K | 85.80K | 98.30K | 112.10K |
| Total Amortization of Deferred Charges | 630.70K | 355.50K | 115.10K | 17.20K | 0.00 |
| Total Other Non-Cash Items | 1.67M | 1.35M | 781.40K | 1.05M | 1.82M |
| Change in Net Operating Assets | 641.10K | 642.80K | 836.70K | 568.40K | 656.30K |
| Cash from Operations | -2.79M | -2.72M | -1.92M | -1.94M | -2.14M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.90K | -5.40K | -- | -- | -- |
| Cash from Investing | -12.90K | -5.40K | -- | -- | -- |
| Total Debt Issued | 1.17M | 1.17M | 988.50K | 576.60K | 70.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.80K | 4.80K | 4.80K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 6.00M | 5.00M | 192.30K | 302.30K | 382.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -846.50K | -786.50K | -23.90K | -- | -- |
| Cash from Financing | 6.33M | 5.39M | 1.16M | 878.90K | 452.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.52M | 2.66M | -758.10K | -1.07M | -1.69M |